Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple sclerosis masquerading as lithium toxicity.

J G Solomon

    The Journal of Nervous and Mental Disease
    |September 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Lithium is an effective treatment for manic-depressive illness, but side effects can occur. This case highlights how other neurological conditions, like multiple sclerosis, can be mistaken for lithium toxicity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prognostic factors for spinal cord myelitis--an analysis of compiled literature data.

    Indian journal of cancer·1998
    Same author

    Possible role of glutathione in predicting radiotherapy response of cervix cancer.

    International journal of radiation oncology, biology, physics·1998
    Same author

    Twins and eating disorders.

    The American journal of psychiatry·1992
    Same author

    Radiotherapy and verrucous carcinoma of the oral cavity. A study of 107 cases.

    Acta oncologica (Stockholm, Sweden)·1992
    Same author

    Usefulness of the dexamethasone suppression test.

    The American journal of psychiatry·1987
    Same author

    Management of the severely demented patient.

    JAMA·1983
    Same journal

    Efficacy and Safety of Aripiprazole in Children and Adolescents With Autism Spectrum Disorder: A Meta-Analysis.

    The Journal of nervous and mental disease·2026
    Same journal

    Metacognitive Interpersonal Group Therapy for Adolescents With Personality Disorders: Results From the METAMIND-A Pilot Randomized Controlled Trial.

    The Journal of nervous and mental disease·2026
    Same journal

    Activation Syndrome in Patients Diagnosed With Major Depressive Disorder for the First Time: The Role of Past Hypomania Symptoms and Atypical Depression as Risk Factors.

    The Journal of nervous and mental disease·2026
    Same journal

    Predicting Social Motivation and Interactions in Schizophrenia: An Ecological Momentary Assessment Study.

    The Journal of nervous and mental disease·2026
    Same journal

    Use of EQUATOR Network Templates in JNMD: The STROBE Guideline for Observational Studies.

    The Journal of nervous and mental disease·2026
    Same journal

    Mental Illness Attributions and Their Association With Psychotherapy Change Process Expectations.

    The Journal of nervous and mental disease·2026
    See all related articles

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Pharmacology

    Background:

    • Lithium is a cornerstone treatment for bipolar disorder (manic-depressive illness).
    • Adverse effects of lithium can manifest at both toxic and therapeutic serum levels.
    • Differentiating drug toxicity from co-existing neurological conditions is clinically challenging.

    Observation:

    • A patient with bipolar disorder on lithium maintenance developed dysarthria and ataxia.
    • These neurological symptoms were initially misattributed to lithium toxicity at therapeutic levels.
    • Symptoms persisted despite dose reduction, prompting further investigation.

    Findings:

    • Neurological consultation confirmed a diagnosis of multiple sclerosis (MS).
    • The patient's symptoms were due to MS, not lithium toxicity.

    Related Experiment Videos

  • This case underscores the importance of considering alternative diagnoses.

    • Implications:

    • Lithium remains a valuable therapeutic agent for bipolar disorder.
    • Clinicians must maintain a high index of suspicion for co-existing conditions when patients present with neurological symptoms.
    • Accurate diagnosis is crucial to avoid unnecessary medication adjustments and ensure appropriate treatment.